Kim Klein

780 total citations
30 papers, 398 citations indexed

About

Kim Klein is a scholar working on Hematology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Kim Klein has authored 30 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 9 papers in Oncology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Kim Klein's work include Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Kim Klein is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Neutropenia and Cancer Infections (8 papers) and Childhood Cancer Survivors' Quality of Life (6 papers). Kim Klein collaborates with scholars based in Netherlands, United States and Germany. Kim Klein's co-authors include Gertjan J.L. Kaspers, Cornelis A.M. van Gestel, Pauline L. Waalewijn‐Kool, Válerie de Haas, James Giordano, M. Kay Garcia, C. Michel Zwaan, Gary T. Jarvis, Leonard N. Matheson and A. John and has published in prestigious journals such as Blood, Spine and British Journal of Haematology.

In The Last Decade

Kim Klein

27 papers receiving 379 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim Klein Netherlands 12 119 78 64 62 51 30 398
Stephen Singleton United Kingdom 5 134 1.1× 134 1.7× 10 0.2× 12 0.2× 10 0.2× 6 582
Shahnaz Ibrahim Pakistan 12 87 0.7× 39 0.5× 5 0.1× 27 0.4× 53 1.0× 51 887
Xuezhen Liu China 11 13 0.1× 57 0.7× 97 1.5× 92 1.5× 7 0.1× 37 649
Yong Chul Shin South Korea 11 14 0.1× 33 0.4× 26 0.4× 10 0.2× 75 1.5× 22 507
Hyun Tae Park South Korea 13 20 0.2× 71 0.9× 26 0.4× 21 0.3× 3 0.1× 27 441
Carol A. Johnston United States 13 26 0.2× 51 0.7× 7 0.1× 14 0.2× 11 0.2× 35 434
Chien-Liang Wu Taiwan 7 13 0.1× 49 0.6× 18 0.3× 219 3.5× 15 0.3× 9 484
Kathleen M. Buckley United States 12 101 0.8× 105 1.3× 3 0.0× 47 0.8× 12 0.2× 31 936
Herbert Juch Austria 11 16 0.1× 452 5.8× 17 0.3× 36 0.6× 4 0.1× 18 657

Countries citing papers authored by Kim Klein

Since Specialization
Citations

This map shows the geographic impact of Kim Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Klein more than expected).

Fields of papers citing papers by Kim Klein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Klein. The network helps show where Kim Klein may publish in the future.

Co-authorship network of co-authors of Kim Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Klein. A scholar is included among the top collaborators of Kim Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Klein. Kim Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touw, Daan J., et al.. (2025). Pharmacokinetics of teicoplanin in paediatric patients—A systematic review of current literature. British Journal of Clinical Pharmacology. 92(2). 396–421.
2.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2024). Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome. European Archives of Psychiatry and Clinical Neuroscience. 274(8). 1945–1957. 5 indexed citations
3.
Njuguna, Festus, et al.. (2024). Childhood cancer care beyond the ‘six common and curable types’: A comparative case series on acute myeloid leukemia in Kenya and the Netherlands. Asia-Pacific Journal of Oncology Nursing. 11(10). 100565–100565.
4.
Cornel, Annelisa M., Anja Krippner‐Heidenreich, Kim Klein, et al.. (2024). Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia. Haematologica. 109(12). 4131–4136. 1 indexed citations
5.
Schild, Ann‐Katrin, Kim Klein, Yasemin Goereci, et al.. (2023). Subjective and Objective Cognitive Deficits in Patients with Post-COVID Syndrome. Zeitschrift für Neuropsychologie. 34(2). 99–110. 13 indexed citations
6.
Klein, Kim, et al.. (2023). Treating CD33-Positive de novo Acute Myeloid Leukemia in Pediatric Patients: Focus on the Clinical Value of Gemtuzumab Ozogamicin. OncoTargets and Therapy. Volume 16. 297–308. 3 indexed citations
8.
Klein, Kim, Jonas Abrahamsson, Barbara De Moerloose, et al.. (2023). Early Peripheral Blood Blast Clearance As a Prognostic Marker for Early Treatment Response in Pediatric Acute Myeloid Leukemia. Blood. 142(Supplement 1). 2950–2950. 1 indexed citations
9.
Schild, Ann‐Katrin, Yasemin Goereci, Kim Klein, et al.. (2022). Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort. Journal of Neurology. 270(3). 1215–1223. 37 indexed citations
10.
Reedijk, Ardine, Kim Klein, J.W.W. Coebergh, et al.. (2018). Improved survival for children and young adolescents with acute myeloid leukemia: a Dutch study on incidence, survival and mortality. Leukemia. 33(6). 1349–1359. 39 indexed citations
11.
Klein, Kim, Henrik Hasle, Jonas Abrahamsson, Barbara De Moerloose, & Gertjan J.L. Kaspers. (2018). Differences in infection prophylaxis measures between paediatric acute myeloid leukaemia study groups within the international Berlin–Frankfürt–Münster (I‐BFM) study group. British Journal of Haematology. 183(1). 87–95. 6 indexed citations
12.
Klein, Kim, Válerie de Haas, & Gertjan J.L. Kaspers. (2018). Clinical challenges in de novo pediatric acute myeloid leukemia. Expert Review of Anticancer Therapy. 18(3). 277–293. 29 indexed citations
13.
Klein, Kim, Válerie de Haas, Ingrid E.M. Bank, et al.. (2017). Clinical and prognostic significance of eosinophilia and inv(16)/t(16;16) in pediatric acute myelomonocytic leukemia (AML‐M4). Pediatric Blood & Cancer. 64(10). 4 indexed citations
14.
Klein, Kim, Eric G. Haarman, Válerie de Haas, et al.. (2016). Glucocorticoid-Induced Proliferation in Untreated Pediatric Acute Myeloid Leukemic Blasts. Pediatric Blood & Cancer. 63(8). 1457–1460. 12 indexed citations
15.
Waalewijn‐Kool, Pauline L., et al.. (2014). Bioaccumulation and toxicity of silver nanoparticles and silver nitrate to the soil arthropod Folsomia candida. Ecotoxicology. 23(9). 1629–1637. 73 indexed citations
16.
Klein, Kim & Gertjan J.L. Kaspers. (2013). A Review of Liposomal Daunorubicin in the Treatment of Acute Leukemia. 9(2). 142–142. 5 indexed citations
17.
Giordano, James, et al.. (2003). Complementary and Alternative Medicine in Mainstream Public Health: A Role for Research in Fostering Integration. The Journal of Alternative and Complementary Medicine. 9(3). 441–445. 26 indexed citations
18.
Matheson, Leonard N., Vert Mooney, Vincent J. Caiozzo, et al.. (1992). Effect of Instructions on Isokinetic Trunk Strength Testing Variability, Reliability, Absolute Value, and Predictive Validity. Spine. 17(8). 914–921. 33 indexed citations
19.
Klein, Kim. (1985). Fundraising for social change. 14 indexed citations
20.
Klein, Kim, et al.. (1962). [Comparative determinations of the heart minute volume with isotopes and physical methods].. PubMed. 74. 922–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026